FDA Inspection 1181809 — Penn Pharmaceutical Services Limited
The FDA completed an inspection of Penn Pharmaceutical Services Limited on Apr 1, 2022 in Tredegar. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 1, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Tredegar (United Kingdom)
Additional details
Mutual Recognition Agreement (MRA)